The new tax law is coming! The authority of the six hot issues responded in this way.
Release time:
2020-08-14
The new tax law is coming! The authoritative departments of the six hot issues responded in this way
The fifth meeting of the 13th National People's Congress Standing Committee 8# June 31 voted and passed the decision on amending the personal income tax law, marking the completion of the seventh overhaul of the tax law.
Why is the "threshold" set at 5000 yuan per month? How much tax can the new tax law reduce for the working class? How exactly can the special additional deduction be deducted? ...... Facing the hot issues of social concern, the General Office of the Standing Committee of the National People's Congress held a press conference in the Great Hall of the People that afternoon, and the relevant persons in charge of the Ministry of Finance and the State Administration of Taxation answered one by one.
Watch 1: The monthly 5000 yuan "threshold" has attracted much attention due to three major considerations
tax basic deduction standard ( is commonly referred to as "threshold" ) . Why is the standard of 5000 yuan per month set?
Vice Minister of Finance Cheng Lihua said that it is mainly based on three considerations:
First, it is determined after taking into account the basic consumption expenditure per capita of urban residents, the average number of people per employee, the consumer price index and other factors. According to the sample survey data of the National Bureau of Statistics, the per capita consumption expenditure borne by urban employees in China in 2017 was about 3900 yuan per month. According to the average annual growth rate of urban residents' consumption expenditure in the past three years, the per capita consumption expenditure in 2018 was about 4200 yuan per month. The basic deduction standard is set at 5000 yuan per month, which not only covers the per capita consumption expenditure, but also reflects a certain forward-looking.
Second, in addition to the basic deduction standard, this amendment has added a number of special additional deductions, expanding the low-grade tax rate range, the majority of taxpayers can enjoy tax reduction dividends to varying degrees, especially the lower-middle income groups benefit more. Based on the factor of raising the basic deduction standard to 5000 yuan per month, the proportion of individual tax payers in urban employment will drop from the current 44% to 15% after the amendment.
Three are two new deductions, one is a special additional deduction for supporting the elderly, and the other is to allow three types of income such as labor remuneration, author's remuneration and royalties to be taxed after deducting the expenses of 20% , which further increases the deduction of expenses for a considerable number of taxpayers.
However, Cheng Lihua said that the "threshold" of 5000 yuan is not fixed and will be dynamically adjusted in the future in combination with deepening the reform of personal income tax and changes in the level of basic consumption expenditure of urban residents.
Point 2: After 10 July 1 , the monthly income below yuan will be reduced by 50% above
. According to the decision, the revised tax law will be implemented from 2019 1 , so that taxpayers can enjoy the tax reduction bonus as soon as possible, starting from 10 April 1 this year, the basic deduction standard for wages and salaries will be raised to 5000 yuan per month, and tax will be calculated according to the new tax rate table. The new tax rate table also applies to business income such as individual industrial and commercial households.
"When paying wages after 10 March 1 , the financial personnel of each enterprise unit must remember when withholding personal income tax, and don't forget to apply the new expense standard and new tax rate table of 5000 yuan." Liu Lijian, chief auditor of the State Administration of Taxation, reminded.
Cheng Lihua said that with the increase of the basic expense standard, the majority of working taxpayers will realize tax reduction to varying degrees, among which the tax burden of taxpayers with monthly income below 2 .02 million yuan can be reduced by more than 50% of . Overall, the tax revenue decreased by 3,200 .6 billion yuan a year 105 the reform. If you consider other deductions, as well as new special additional deductions, the tax burden will be further reduced.
56 yuan
. In other words, the tax is calculated at a 20% discount to the original income.
, and a discount of 70% of the 126 of is further given. The two factors are superimposed, and the remuneration income is actually equivalent to the calculation of tax at the discount of 5.6 . "That is to say, the remuneration income of 100 yuan will be calculated and taxed according to 56 yuan, which greatly reduces the tax burden." Cheng Lihua said. Aspect 4: Special Additional Deductions Preliminary Consideration Quota or Limit Standard
Children's Education, Continuing Education, Support for the Elderly... After the amendment, six special additional deductions will be added to the tax law, but according to what standard will be deducted?
According to the authorization of the tax law, the State Council will make specific provisions on the scope, standards and implementation steps of special additional deductions.
Cheng Lihua said that preliminary consideration should be given to setting a certain limit or quota standard for special additional deductions, which should not only ensure that taxpayers can pay taxes conveniently and relevant expenses can be reasonably deducted, but also reflect the fairness of the policy so that the majority of taxpayers can really enjoy the dividends of tax reduction.
"the implementation of special additional deduction is a new attempt, which puts forward higher requirements for taxpayers' tax declaration and tax collection and management by tax authorities." Cheng Lihua said that in order to ensure the smooth implementation of this policy, the Ministry of Finance will combine the existing collection and management conditions and design the relevant system based on the principle of simplifying procedures and facilitating operation.
Point 5: The design of the highest tax rate takes into account the adjustment of income distribution requirements
personal income tax 45%
# Wang Jianfan, Director of the Tax Administration Department of the Ministry of Finance of 158, said that for high-income people, the adjustment has raised the basic deduction standard, increased special additional deductions, and also achieved tax cuts. However, due to the large gap in income distribution in China, the design of the tax rate structure of personal income tax, including the design of the highest marginal tax rate, should take into account the requirements of regulating income distribution.
as far as possible; can enjoy prepayment, individuals can provide special additional deduction information to the unit, and the unit will deduct according to the facts when paying wages and withholding personal income tax every month.
Liu Lijian said that even if the withholding and prepayment link is not enjoyed or the deduction is not in place, the tax refund can be applied for in the second year when the final settlement is processed. In addition, the tax department will share third-party information with multiple departments, check the true accuracy of the declared information, minimize the provision of supporting materials by taxpayers, and "let information run more on the Internet and let taxpayers run less on the road". ( article comes from network
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31